Investors
Revance is financed by a blue chip roster of healthcare investors, including Essex Woodlands Health Ventures, Vivo Ventures, Technology Partners, Shepherd Ventures, Palo Alto Investors, Medicis Pharmaceutical Corporation, Bio*One Capital, Pac-Link Ventures, Leader Ventures, and Horizon Technology Finance.
Essex Woodlands Health Ventures
Essex Woodlands one of the world's largest and most established
healthcare venture capital firms. For over 20 years, the firm has maintained its dedicated
focus to diversified healthcare investing-primarily serving as lead
investor in the founding or the critical financings of over 100
healthcare companies in pharmaceutical, biotechnology, medical device,
services and information technology sectors.
www.ewhv.com
Vivo Ventures
Vivo Ventures is currently making investments
from its $275M sixth fund into promising biotechnology and life science
companies. With over 90 years of scientific and operational expertise
in biotechnology, Vivo makes investment decisions for the Funds and
helps its portfolio companies develop corporate strategy, arrange
licensing agreements and strategic alliances, recruit key management
personnel, and acquire new products and technology to accelerate growth.
www.bioasia.com
Technology Partners
Founded over 20 years ago, Technology
partners manages a total of approximately $700 million of venture
capital. Investments are being made currently from Technology Partners
VIII, L.P., a $300 million fund.
www.technologypartners.com
Shepherd Ventures
Shepherd Ventures is a venture capital fund
whose mission is to generate significant capital appreciation through
first and later stage investments in carefully selected, wisely
shepherded growth companies. Shepherd Ventures is located in San Diego,
part of Southern California's Tech Coast, with easy access to other
technology centers throughout the Southwest.
www.shepherdventures.com
Palo Alto Investors
Palo Alto Investors is an SEC-registered
investment advisor providing money management services to institutional
clients and high net worth individuals. Our approach is deeply
fundamental and our goal is to serve clients by delivering sustained,
high rates of return over time. We offer several strategies, each of
which has the same basic approach and goal, but focus on different
market segments.
www.pa-investors.com
Medicis Pharmaceutical Corporation
Medicis is the leading
independent specialty pharmaceutical company in the United States
focusing primarily on the treatment of dermatological and podiatric
conditions and aesthetics medicine. Medicis has leading branded
prescription products in a number of therapeutic categories, including
acne, fungal infections, psoriasis, rosacea, seborrheic dermatitis, and
skin and skin-structure infections. Additionally, the company markets
the leading dermal filler in the U.S., Restylane.
www.medicis.com
Bio*One Capital
Bio*One Capital is the dedicated biomedical
sciences investment arm of the Singapore Economic Development Board
("EDB"). We manage S$1.2 billion (approximately US$790 million) in
funds that invest in global biotechnology, specialty pharmaceuticals,
medical technology companies and start-ups in Singapore. In addition to
generating long-term capital gains, we seek to accelerate the growth of
a vibrant biomedical sciences industry in Singapore through scientific
and economic contributions from our investment activities. Bio*One
Capital currently has a portfolio of over 60 companies worldwide.
www.bio1capital.com
Pac-Link Ventures
Pac-Link seeks to invest in companies in
which our unique resources and insights can generate significant gains
for all shareholders. We work closely with company managers to minimize
risks, maximize opportunities, and help build rapidly growing
businesses in Asia and North America. Pac-Link connects the best of
emerging companies with the best business relationships to achieve
maximum growth potential. Pac-Link was established in 1998 and
currently manages nine funds with total contributions of about US$370
million.
www.paclinkventure.com
Leader Ventures
Leader Ventures is a private investment firm providing blended debt and equity financing to a
diversified portfolio of private and public companies. With offices in San Francisco and
Menlo Park, the firm invests primarily in the US and employs a variety of loan plus equity
structures to invest in companies at different developmental stages across a variety of
industry segments.
www.leaderventures.com
Horizon Technology Finance
Horizon Technology Finance Management LLC is a privately-held independent venture debt
finance company that provides senior and subordinated venture debt financing solutions to
venture capital-backed technology and life science companies through its affiliated
investment finance company Compass Horizon Funding Company LLC. The Horizon team
has provided over $2 billion in financing to more than 750 venture capital-backed technology
and life science companies over a span of 20 years. Horizon has offices in Farmington, CT
and the San Francisco, CA area.
www.horizontechfinance.com